MasterPharm LLC

FDA Regulatory Profile

MasterPharm LLC has 28 FDA recalls (2 Class I), 3 inspections, 0 510(k) clearances and 2 compliance actions on record.

Latest recall
D-1432-2020 · Class II · Jul 2, 2020
Latest inspection
Jun 15, 2020 · OAI

Reviewing MasterPharm LLC as a supplier? Request a free FDA snapshot: name up to five suppliers and get a PDF of their public FDA record, with sources and dates. You do not need an API connection. Each snapshot is prepared by hand.

Check this supplier

Or check MasterPharm LLC yourself in Claude, Cursor or ChatGPT: get the full FDA risk summary, with inspections, warning letters, Form 483s and import alerts by site.

Get a free API key

Summary

Record counts and when each FDA source was last refreshed
RecordsCountLast refreshedSource as ofStatus
Recalls28 (2 Class I)Nov 4, 2026 (checked Nov 8, 2026, unchanged)File dated Nov 3, 2026Current
510(k) clearances0Nov 8, 2026File dated Nov 2, 2026Current
Inspections3Nov 9, 2026Newest record Oct 28, 2026Current
Compliance actions2Nov 2, 2026Newest record Oct 29, 2026Current

Recent Recalls

NumberClassProductDate
D-1432-2020Class IIProgesterone 50 mg Modified Release Capsule, 90 capsules per bottle, MasterPharm, 115-02 Liberty…Jul 2, 2020
D-1439-2020Class IITadalafil 3 mg Capsule, 90 capsules per bottle, MasterPharm, 115-02 Liberty Ave, Richmond Hill, NY…Jul 2, 2020
D-1429-2020Class IIProgesterone 300 mg Troche, 30 troches per bottle, MasterPharm, 115-02 Liberty Ave, Richmond Hill…Jul 2, 2020
D-1421-2020Class IIEstriol 8 mg Capsule, 90 capsules per bottle, MasterPharm, 115-02 Liberty Ave, Richmond Hill, NY…Jul 2, 2020
D-1425-2020Class IIMinoxidil/Biotin 1.25mg/5mg Capsule, 90 capsules per bottle, MasterPharm, 115-02 Liberty Ave…Jul 2, 2020
D-1423-2020Class IIFormula 82F (Minoxidil 5%/Tretinoin 0.01%/Fluocinolone Acetonide 0.01%/Finasteride 0.25%), 0.5 FL OZ…Jul 2, 2020
D-1424-2020Class IIFormula 82M (Minoxidil 5%/Tretinoin 0.01%/Fluocinolone acetonide 0.01%), a) 0.5 FL OZ (15 mL), b) 2…Jul 2, 2020
D-1436-2020Class IITadalafil 12 mg Capsule, 90 capsules per bottle, MasterPharm, 115-02 Liberty Ave, Richmond Hill, NY…Jul 2, 2020
D-1428-2020Class IIProgesterone 150 mg Troche, 30 troches MasterPharm, 115-02 Liberty Ave, Richmond Hill, NY 11419…Jul 2, 2020
D-1431-2020Class IIProgesterone 200 mg Troche, 30 troches per bottle, MasterPharm, 115-02 Liberty Ave, Richmond Hill…Jul 2, 2020
D-1434-2020Class IIProgesterone Modified Release 200 mg Capsule, 90 capsules per bottle, MasterPharm, 115-02 Liberty…Jul 2, 2020
D-1438-2020Class IITadalafil 26 mg Capsule, 90 capsules per bottle, MasterPharm, 115-02 Liberty Ave, Richmond Hill, NY…Jul 2, 2020
D-1427-2020Class IIProgesterone (Modified Release) 150 mg Capsule, 90 capsules per bottle, MasterPharm, 115-02 Liberty…Jul 2, 2020
D-1435-2020Class IISildenafil 50 mg Troche, 30 troches per bottle, MasterPharm, 115-02 Liberty Ave, Richmond Hill, NY…Jul 2, 2020
D-1442-2020Class IIVardenafil 20 mg Troche, 30 troches per bottle, MasterPharm, 115-02 Liberty Ave, Richmond Hill, NY…Jul 2, 2020
D-1430-2020Class IIProgesterone (Rapid-Dissolve) 150 mg Tablet, 30 tablets per bottle, MasterPharm, 115-02 Liberty Ave…Jul 2, 2020
D-1418-2020Class IICalcium citrate tetrahydrate USP powder, 100 gm container, MasterPharm, 115-02 Liberty Ave, Richmond…Jul 2, 2020
D-1437-2020Class IITadalafil 18 mg Capsule, 90 capsules per bottle, MasterPharm, 115-02 Liberty Ave, Richmond Hill, NY…Jul 2, 2020
D-1420-2020Class IIEstriol 6 mg Capsule, 90 capsules per bottle, MasterPharm, 115-02 Liberty Ave, Richmond Hill, NY…Jul 2, 2020
D-1433-2020Class IIProgesterone Modified Release 100 mg Capsule, 90 capsules per bottle, MasterPharm, 115-02 Liberty…Jul 2, 2020

Recent FDA Inspections

DateSiteProductClassificationFEI
Jun 15, 2020South Richmond Hill, NYDrugsOfficial Action Indicated (OAI)3005734706
Jan 30, 2017South Richmond Hill, NYDrugsVoluntary Action Indicated (VAI)3005734706
May 6, 2015South Richmond Hill, NYDrugsOfficial Action Indicated (OAI)3005734706

NAI means no objectionable conditions or practices were found during the inspection. VAI means objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action. OAI means regulatory and/or administrative actions are recommended.

FDA-Inspected Facilities

FacilityLocationInspectionsLatest
FEI 3005734706South Richmond Hill, NY3Jun 15, 2020

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.